2007
DOI: 10.1002/hc.20245
|View full text |Cite
|
Sign up to set email alerts
|

Substituted pyridopyrimidinones, 1: Convenient PTC alkylation and halogenation of 2‐hydroxy‐4H‐pyrido[1,2‐a]pyrimidin‐4‐one

Abstract: Alkylation of 2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (1) was investigated under solidliquid phase transfer catalysis conditions (PTC), using tetrabutylammonium bromide and potassium carbonate. The reaction with alkyl halides led to the formation of various 2-alkoxy products, in fair yields. Reaction of compound 1 with

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
9
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 19 publications
2
9
0
Order By: Relevance
“…4‐Hydroxycoumarin ( 2 ) and 4(6)‐aminouracil were supplied by Merck and 5‐amino‐3‐methyl‐1 H ‐pyrazole by Aldrich. 4‐Hydroxy‐1‐methylquinolin‐2(1 H )‐one ( 4 ) , 2‐hydroxy‐4 H ‐pyrido[1,2‐ a ]pyrimidin‐4‐one ( 6 ) , and 4‐hydroxy‐2 H ‐pyrano[3,2‐ c ]quinoline‐2,5(6 H )‐dione ( 8 ) were prepared according to literature.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…4‐Hydroxycoumarin ( 2 ) and 4(6)‐aminouracil were supplied by Merck and 5‐amino‐3‐methyl‐1 H ‐pyrazole by Aldrich. 4‐Hydroxy‐1‐methylquinolin‐2(1 H )‐one ( 4 ) , 2‐hydroxy‐4 H ‐pyrido[1,2‐ a ]pyrimidin‐4‐one ( 6 ) , and 4‐hydroxy‐2 H ‐pyrano[3,2‐ c ]quinoline‐2,5(6 H )‐dione ( 8 ) were prepared according to literature.…”
Section: Methodsmentioning
confidence: 99%
“…and 4(6)-aminouracil were supplied by Merck and 5-amino-3methyl-1H-pyrazole by Aldrich. 4-Hydroxy-1-methylquinolin-2(1H)-one (4)[27], 2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (6)[28], and 4-hydroxy-2H-pyrano[3,2-c]quinoline-2,5(6H)dione(8) [27] were prepared according to literature.10-Methyl-6H,8H-dichromeno[2,3-b:3′,4′-e]pyridine-6,8dione(3). A mixture of 2-amino-6-methylchromone-3-carboxaldehyde (1), (0.61 g, 3 mmol) and 4-hydroxycoumarin (2), (0.49 g, 3 mmol), in DMF (10 mL) containing a few drops of DBU, was heated under reflux for 2 h. The yellow crystals obtained after cooling were filtered off and crystallized from DMF/H 2 O to give compound 3 as yellow crystals, mp > 300°C, yield 0.53 g (54%).…”
mentioning
confidence: 99%
“…For example, this structural pattern is present in the known psychotropic agents risperidone and paliperidone [2,3], the human leukocyte elastase inhibitor SSR69071 [4], the antiallergic agent ramastine [5], and the antioxidants 2-arylpyrido[1,2-a]pyrimidin-4-ones [6] (Figure 1). As a continuation to our previous work [7], we utilized ethyl [(4-oxo-4H-pyrido[1,2-a]pyrimidin-2yl)oxy]acetate (1) to obtain novel bi-heterocyclic ethers which are of expected antipsychotic activity. This expected biological activity may be due to the presence of pyridopyrimidinone and other known biologically active heterocycles such as pyrazole, imidazole, triazole, oxadiazole, pyrone, coumarin, and quinolinone in one-molecular frame [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…1 It is well-known that this type of α-haloheterocyclic compounds are susceptible to synthetically important nucleophilic substitutions. [2][3][4][5] Many hetero-fused pyrimidines exhibit attractive cancer chemotherapy properties as antitumor agents.…”
Section: Introductionmentioning
confidence: 99%